DEVELOP AND PRODUCE PHARMACEUTICAL DOSAGE FORMS

开发和生产药物剂型

• 批准号: 3616707
• 负责人: TING-FONG CHIN
• 金额: $ 46.36万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 1989
• 资助国家: 美国
• 起止时间: 1989-06-30 至 1992-06-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3616707
• 关键词: dosage forms; drug metabolism; drug quality /standard; neoplasm /cancer pharmacology

The function of this contract is to provide pharmaceutical services in the following areas: development of freeze dried and liquid small volume parenterals, development of the tablet and capsule solid oral dosage forms, and production of sterile freeze dried dosage forms, small volume parenterals, tablets and capsules. Data obtained from this contract will 1) be used to support IND applications submitted by the National Cancer Institute to the U. S. Food and Drug Administration. 2) be provided to other NCI contractors engaged in large scale dosage form manufacture and analytical evaluation of these dosage forms and 3) be provided to physicians, pharmacists, nurses and other medical personnel handling these products in a clinical setting.

本合同的功能是提供药学服务 在以下领域：开发冻干和液体 小体积胃肠外制剂，片剂和胶囊剂的开发 固体口服剂型和无菌冻干制剂的生产 剂型、小体积肠胃外制剂、片剂和胶囊剂。 从本合同中获得的数据将1）用于支持IND 美国国家癌症研究所向美国癌症研究所提交的申请。 S.食品药品监督管理总局. 2)提供给其他NCI 从事大规模剂型生产的承包商， 这些剂型的分析评价和3）提供给 医生、药剂师、护士和其他医务人员 在临床环境中处理这些产品。